Citations 1
540 A novel antibody that induces PD-L1 degradation results in enhanced tumor responses in a humanized PD-L1 breast carcinoma mouse model compared to Atezolizumab
Liu, Xin , Harrington, Sue, Lucien-Matteoni, Fabrice, Hsu, Michelle A. , Barham, Whitney , Harrington, Sue, Dong, Haidong
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A614-A614
